CD4 and breast cancer: In agreement with this, but in a different setting characterized by significant inflammation, it has been found that CD39+CD4+ tumor-infiltrating Tconv cells from patients with breast cancer display features of exhaustion while retaining the ability to produce effector cytokines (56).